Forget Me Not: Closing the Gap After a Fragility Fracture

Slides:

Advertisements

Similar presentations

OSTEOPOROSIS Definitions Definitions Causes Causes Investigations Investigations Treatments Treatments Case studies Case studies.

Advertisements

Business Process Outsourcing Axean PacificIntellix.

Effects of Glycomacropeptide, Amino Acid & Casein Diets on Osteopenia in PKU Mice Denise M. Ney, PhD, RD Professor of Nutritional Sciences Waisman Center.

Osteoporosis 9 th January 2013 Dr Julian Tomkinson.

Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.

Osteoporosis Prevention in Inhaled Cortico-steroid Users Osteoporosis Prevention in Inhaled Cortico-steroid Users Principle Investigators: Hoan Linh Banh,

PubMed was searched for randomized clinical trials published between 2007 and 2012 in the New England Journal of Medicine (NEJM) Trials were included if.

Hip Fracture Dr Janet Lippett Consultant Orthogeriatrician October 2011.

Organization of Health Care Services for the Elderly: Russia A.M.Clarfield MD, FRCPC Professor of Gerontology Ben Gurion University, Israel.

The Pharmaceutical Industry. Industry introduction Opportunity How to get into this industry ?

Bone Health and Osteoporosis

Fall Prevention subtitle.

1 Osteoporosis Treatment in Frail Populations: A Framework for Decision- Making Cathleen Colón-Emeric, MD, MHSc Durham VA GRECC and Duke University Medical.

What is a DEXA Scan Anyway?: The third in the series of screening protocol updates Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino.

Denosumab NICE technology appraisal guidance 204 October 2010.

Denosumab Treatment for 5 Years of Postmenopausal Women With Osteoporosis: Results From the First Two Years of the FREEDOM Trial Extension Henry G Bone1,

Osteoporosis Daniel D Erica.

Burden of Musculoskeletal Diseases, Third Edition Data to address goals of the Global Alliance for Musculoskeletal Health History declared United.

1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium... 1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium...

The Different Modalities of Treatment of Osteoporosis Fracture Kuo-Ti Peng, M.D. Kuo-Ti Peng, M.D. Department of Orthopedics, Chang Gung Memorial Hospital.

How Much AF is Too Much AF? Do I Initiate Anticoagulation Based on AF Detected on Device Monitoring? Kenneth W. Mahaffey, MD, FACC Professor of Medicine,

TAKING CARE OF YOU Kingston Hospital NHS Trust NHS Secondary Prevention of Osteoporotic Fragility Fractures - results from 5 years of audit data Hamid.

Hippisley-Cox, J., Bayly, J., Potter, J., Fenty, J. & Parker, C. (2007) Evaluation of standards of care for osteoporosis and falls in primary.

Patients’ preferences for preventive osteoporosis drug treatment EW de Bekker-Grob ML Essink-Bot WJ Meerding HAP Pols BW Koes EW Steyerberg Dept. Public.

Osteoporosis in the European Union: medical management, epidemiology and economic burden (EU-27 Report) EU Osteoporosis Consultation.

UNIVERSITY of DERBY Implementing TA 161 and 204 in the real world Dr. Jonathan Bayly Visiting Fellow, University of Derby.

Food and Drug Administration Regulatory Implications of The WHI Study Eric Colman, MD Center for Drug Evaluation and Research Division of Metabolic and.

Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.

Jacobi Ambulatory Care Service The next steps…. Jacobi Ambulatory Care Service Doing More by doing less Tips.

Know the Numbers=ROI for Employer & Employee Health Promotion & Prevention as a Business Strategy (Total Population Management) MICHIGAN PURCHASERS HEALTH.

Fracture Prognosis. Fracture Morbidity Compared to men, Women: - Are almost twice as likely to survive - Are more likely to return to home - Are more.

By: Stephanie, Jannetta, and Safiyyah. Osteoporosis is a condition in which there is a progressive loss of bone tissue. Through this, bones weaken and.

Improving Evaluation and Treatment for Osteoporosis Following Distal Radial Fractures by Tamara D. Rozental, Eric C. Makhni, Charles S. Day, and Mary L.

Osteoporosis By, Shelby, Eduardo, and Varshini. What is Osteoporosis? Osteoporosis means porous bone It is a disease associated with progressive bone.

Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.

OSTEOPOROSIS Dr Annie Cooper Consultant Rheumatologist Royal Hampshire County Hospital Winchester.

R1 김형오 / Prof. 김덕윤 1.  Osteoporosis  Asian region is considered to be on the verge of an emerging osteoporosis epidemic  50% of the world’s osteoporotic.

Osteoporosis Vinod Kurup, MD December 22nd, 2006 CC-BY-SA.

World Osteoporosis Day Love Your bones —Protect your future!

Rational Use of DXA-BMD

Petranova T1, Boyanov M2, Shinkov A3, Petkova R4, Psachoulia E5

2016 World Osteoporosis Day Report

Export of innovative food supplement OSTEOMED

Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis Peyman Hadji Critical Reviews in Oncology.

Volume 15, Issue 1, Pages S20-S28 (January 2012)

THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.

Chapter 55: Cost-Effectiveness of Osteoporosis Treatment

THE SELF MEDICATION MANUFACTURERS ASSOCIATION OF SOUTH AFRICA (SMASA)

Health Science 1 Project

The Future of Osteoporosis: Improving Care Along the Way

11/7/2018 OSTEOPOROSIS.

Osteoporosis Definition

Dr.farahani MD-Mph Arak health center

Ronald D. Emkey, MD, Mark Ettinger, MD

Adjusted mortality risk estimate 209 hip fracture, >50yeras

Guidance for Bone Health in Parkinson's

The erlangen fitness osteoporosis prevention study: a controlled exercise trial in early postmenopausal women with low bone density—first-year results

The Research Question RESEARCH METHOD

Deciding on Pharmacological Treatment Post Fracture

Deciding on Pharmacological Treatment Post Fracture

Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023.

There are many things that you can do to improve your bone health.

Figure 1: Assessment of basal 10-year risk of fracture with the 2010 tool of the Canadian Association of Radiologists and Osteoporosis Canada. Figure 1:

Patient characteristics associated with inpatient mortality within 1 year after hip fracture surgery (multivariable logistic regression model adjusted.

Generic Fosamax: An overview It is a generic version of Fosamax. It belongs to pharmacological class of bisphosphonates. It is widely prescribed for treating.

Clinical Practice Guidelines: What, Why, Who?

Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.

Maintaining bone health while on ADT for Prostate Cancer

Subjects Randomized to Denosumab or Bisphosphonate Therapy

Presentation transcript:

Forget Me Not: Closing the Gap After a Fragility Fracture Kenneth W. Lyles, MD Duke University and VA Medical Centers Durham, NC 27710 May 4,2013

Conflict of Interest Research Support: Novartis, Alliance for Better Bone Health, Amgen Consultant: Novartis, Procter & Gamble, Merck, Amgen, Kirin Pharmaceutical, GTx, Eli Lilly, GSK, Bone Medical Ltd., Wyeth, Osteologix Use Patent Co-Inventor: “Methods for preventing or reducing secondary fractures after hip fracture”, US Patent 20050272707 Patent Inventor: “Medication Kits and Formulations for Preventing, Treating or Reducing Secondary Fractures After Previous Fracture” Provisional Patent Application Co-Inventor “Bisphosphonates and Mortality Reduction”

Osteoporosis Management in Women Who Had a Fracture Women over 67 years of age who suffered a fracture and then had a BMD measurement or prescription for a drug to treat or prevent osteoporosis in the six months after the fracture. 2003 18.0% 2008 20.7% 2004 19.0% 2009 20.7% 2005 20.1% 2010 20.7% 2006 21.8% 2011 22.8% 2007 20.4% http://www.ncqa.org 5/1/2013